Education
About Us
Working with TipRanks
Follow Us
Yves-Stephane Couture Insider Profile
4 Followers
Yves-Stephane Couture, Chief Operating Officer at Diagnos, holds 191.67K shares in Diagnos (Ticker: TSE:ADK). Most recently, Yves-Stephane Couture Bought 66,666 shares of Diagnos on Dec 09, 2025 for an estimated value of C$20.00K.
Yves-Stephane Couture has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Yves-Stephane Couture's holdings
Insider Roles
Chief Operating Officer
Roles that Yves-Stephane Couture holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Yves-Stephane Couture
Yves-Stephane Couture's Trading History
List of latest transactions for each holding click on a transaction to see Yves-Stephane Couture's performance on stock
You May Also Like
Yves-Stephane Couture insider profile FAQ
What is the percentage of profitable transactions made by Yves-Stephane Couture?
The percentage of profitable transactions made by Yves-Stephane Couture is ―.
What is the average return per transaction made by Yves-Stephane Couture?
The average return per transaction made by Yves-Stephane Couture is ―.
What stocks does Yves-Stephane Couture hold?
Yves-Stephane Couture holds: TSE:ADK stocks.
What was Yves-Stephane Couture’s latest transaction?
Yves-Stephane Couture latest transaction was an Informative Buy of C$20.00K.
What was Yves-Stephane Couture's most profitable transaction?
Yves-Stephane Couture’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Yves-Stephane Couture's role in Diagnos?
Yves-Stephane Couture's role in Diagnos is Chief Operating Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.